ProKidney shares are trading sharply higher Wednesday morning. The stock is gaining following a marked surge on Tuesday driven by positive clinical trial data for its CKD treatment. read more
Needham’s analyst Laura Martin maintains Buy rating for Roku (ROKU) and raises price target to $100, citing improving labor productivity metrics and expected positive trajectory with new CFO. ROKU’s revenue-based labor efficiency grew 34% over 3 years, behind only Amazon and Meta Platforms. Latest Ratings for ROKU Date Firm Action From To Feb 2022 Morgan…
Hims & Hers announced plans to expand its weight loss program to Canada in 2026 in connection with the availability of generic semaglutide anywhere in the world. read more
Ripple (CRYPTO: XRP) has announced that the Bank of New York Mellon (NYSE:BKAG) will serve as the primary custodian for reserves backing its read more
Shares of Sharplink Gaming Inc (NASDAQ:SBET) are on watch again on Wednesday, building on momentum fueled by the company’s pivot to an Ethereum (CRYPTO: ETH) focused treasury strategy. read more
Stablecoins are now facilitating nearly $800 billion in digital transactions each month, positioning themselves as credible challengers to traditional payment networks like Visa (NYSE:V read more
